Nannapaneni et al. and Chen with co-authors showed that the co-expression of p53 and FGFR3 in oropharyngeal cancers associated with worse prognosis, whereas Mhavec-Fauceglia with colleagues found that NMIBC with the FGFR3(+)/p53(−) phenotype had distinctive meaning in tumorigenesis [23,24,25]. The gene discussed is TP53; the disease is oropharynx cancer.